These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38181066)

  • 21. Costs of in- and outpatient respiratory disease and the seasonal influenza vaccination program in Armenia - 2020-2021.
    Gobin S; Sahakyan G; Kusi Appiah M; Manukyan A; Palayan K; Ebama M; Vanyan A; McCarron M; Bresee J
    Vaccine; 2024 Oct; 42 Suppl 4(Suppl 4):126007. PubMed ID: 38839517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa.
    McMorrow ML; Tempia S; Walaza S; Treurnicht FK; Ramkrishna W; Azziz-Baumgartner E; Madhi SA; Cohen C
    Vaccine; 2019 Jan; 37(1):25-33. PubMed ID: 30471956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluations of assisted reproductive technologies in high-income countries: a systematic review.
    Olive E; Bull C; Gordon A; Davies-Tuck M; Wang R; Callander E
    Hum Reprod; 2024 May; 39(5):981-991. PubMed ID: 38438132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccines for preventing influenza in healthy adults.
    Demicheli V; Jefferson T; Ferroni E; Rivetti A; Di Pietrantonj C
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD001269. PubMed ID: 29388196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability.
    Hendriks J; Hutubessy RCW; Grohmann G; Torelli G; Friede M; Kieny MP
    Vaccine; 2018 Jun; 36(28):3993-3997. PubMed ID: 29866617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review.
    Fesenfeld M; Hutubessy R; Jit M
    Vaccine; 2013 Aug; 31(37):3786-804. PubMed ID: 23830973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical Analysis of Economic Evaluation of the Childhood Rotavirus Vaccination in Low- and Lower-Middle-Income Countries: A Systematic Review.
    Ray S; Pathak S; Kshtriya P
    Value Health Reg Issues; 2023 Nov; 38():18-28. PubMed ID: 37437462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study.
    Bonnet G; Bimba J; Chavula C; Chifamba HN; Divala TH; Lescano AG; Majam M; Mbo D; Suwantika AA; Tovar MA; Yadav P; Ekwunife O; Mangenah C; Ngwira LG; Corbett EL; Jit M; Vassall A
    PLoS Med; 2024 Jul; 21(7):e1004429. PubMed ID: 39024370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries.
    Lall D; Cason E; Pasquel FJ; Ali MK; Narayan KM
    COPD; 2016; 13(1):93-9. PubMed ID: 26418892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1555-1576. PubMed ID: 33297613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study.
    Waterlow NR; Radhakrishnan S; Dawa J; van Leeuwen E; Procter SR; Lambach P; Bresee J; Mazur M; Eggo RM; Jit M
    BMC Med; 2023 Mar; 21(1):106. PubMed ID: 36949456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
    Jorgensen P; Mereckiene J; Cotter S; Johansen K; Tsolova S; Brown C
    Vaccine; 2018 Jan; 36(4):442-452. PubMed ID: 29287683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cost-effectiveness of vaccines for the prevention of seasonal influenza in different age groups: a systematic review].
    Valcárcel Nazco C; García Lorenzo B; Del Pino Sedeño T; García Pérez L; Brito García N; Linertová R; Ferrer Rodríguez J; Imaz Iglesia I; Serrano Aguilar P
    Rev Esp Salud Publica; 2018 Oct; 92():. PubMed ID: 30327454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysis.
    Yang J; Atkins KE; Feng L; Baguelin M; Wu P; Yan H; Lau EHY; Wu JT; Liu Y; Cowling BJ; Jit M; Yu H
    BMC Med; 2020 Apr; 18(1):90. PubMed ID: 32284056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.
    Molnar D; Anastassopoulou A; Poulsen Nautrup B; Schmidt-Ott R; Eichner M; Schwehm M; Dos Santos G; Ultsch B; Bekkat-Berkani R; von Krempelhuber A; Van Vlaenderen I; Van Bellinghen LA
    Hum Vaccin Immunother; 2022 Nov; 18(5):2058304. PubMed ID: 35486410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children.
    Falcón-Lezama JA; Saucedo-Martínez R; Betancourt-Cravioto M; Alfaro-Cortes MM; Bahena-González RI; Tapia-Conyer R
    BMC Infect Dis; 2020 Mar; 20(1):240. PubMed ID: 32197591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.
    Prosser LA; Lavelle TA; Fiore AE; Bridges CB; Reed C; Jain S; Dunham KM; Meltzer MI
    PLoS One; 2011; 6(7):e22308. PubMed ID: 21829456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries.
    Wright CM; Boudarène L; Ha NT; Wu O; Hawkins N
    BMC Public Health; 2018 Mar; 18(1):373. PubMed ID: 29558894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.